Protein Structure Explained: Primary to Quaternary | Biochemistry

Protein denaturation is the loss of native structure without breaking peptide bonds, caused by heat, pH changes, organic solvents, heavy metals, high salt concentrations, or radiation. Denatured proteins lose biological activity, become insoluble, and are more susceptible to proteolysis. Protein misfolding causes diseases when proteins fail to fold correctly and form insoluble aggregates. Examples include Alzheimer's disease (amyloid-beta and tau protein aggregates), Parkinson's disease (alpha-synuclein aggregates), Huntington's disease (huntingtin protein aggregates), and prion diseases (misfolded prion proteins). These diseases are characterized by progressive neurodegeneration and accumulation of insoluble protein aggregates.

Protein misfolding occurs when proteins lose their native conformation, becoming biologically inactive and insoluble due to exposed hydrophobic residues; while cells have quality control mechanisms (renaturation by chaperones and ubiquitin-mediated degradation), failures lead to aggregation and disease. Alzheimer's disease involves amyloid-beta peptide aggregation forming plaques and neurofibrillary tangles from tau protein phosphorylation, while prion diseases involve conversion of normal PrP^C to pathological PrP^Sc, which acts as a template for converting additional normal proteins, making prions infectious agents that cause invariably fatal neurodegeneration.

Protein misfolding leads to severe pathological consequences including neurodegenerative diseases. Christian Anfinsen demonstrated that proteins can spontaneously refold into their native structure after denaturation, proving that amino acid sequence alone encodes folding information. However, when misfolding occurs, proteins may form rigid amyloid structures that aggregate into long fibrils. These amyloid fibrils are highly stable and resistant to cellular degradation, accumulating in tissues and causing diseases including Alzheimer's, Huntington's, and Parkinson's. Prions represent a particularly dangerous form of misfolded proteins—pure protein particles that can induce normal proteins to adopt abnormal conformations, creating self-propagating infectious agents. Stanley Prusiner received the Nobel Prize in 1997 for discovering prions, which cause transmissible spongiform encephalopathies like Creutzfeldt-Jakob disease and bovine spongiform encephalopathy (mad cow disease).

Protein denaturation refers to the alteration of protein structure (secondary, tertiary, or quaternary) caused by denaturing agents like UV rays, heat, or X-rays, while the primary structure (peptide bonds) remains intact; chaperone proteins (heat shock proteins such as HSP 40, 70, 90) protect proteins from denaturation through the action of enzymes protein disulfide isomerase and peptidylpropyl isomerase; when protein misfolding occurs, misfolded proteins can lead to either prion diseases (rapidly progressive, severe conditions like Creutzfeldt-Jakob disease, Kuru, and familial fatal insomnia) or prion-related disorders (slowly progressive conditions like Alzheimer's disease, Parkinson's disease, Huntington's disease, and Lewy body dementia); ubiquitin, a 76-amino acid protein, marks defective proteins for degradation by attaching to them (called the 'kiss of death'), allowing proteasomes to recognize and destroy these proteins; proteasomal enzyme inhibitors like bortezomib are used clinically in treating multiple myeloma, where diagnosis relies on the CRAB criteria (hypercalcemia, renal failure, anemia, bone lesions).

Defects in protein quality control lead to accumulation of abnormal proteins causing neurodegenerative diseases. Alzheimer's disease results from mutations in APP, PSEN1, PSEN2, and APOE genes, leading to accumulation of beta-amyloid plaques extracellularly and neurofibrillary tangles (hyperphosphorylated tau proteins) intracellularly. This damages the cholinergic neurons of the medial temporal lobe, reducing acetylcholine levels and causing dementia. Treatment involves cholinesterase inhibitors like donepezil and rivastigmine. Prion diseases involve conversion of normal PrP^C to infectious PrP^Sc, which catalyzes further conversion of normal proteins. Examples include Creutzfeldt-Jakob disease, kuru, and Gerstmann-Straussler-Scheinker syndrome.

Hemoglobin exhibits cooperative oxygen binding, where oxygen binding to one subunit increases affinity for remaining subunits, producing a sigmoidal binding curve. Unlike myoglobin's single-chain structure, hemoglobin is a tetramer (α₂β₂ in adults) with remarkable structural similarity to myoglobin subunits. Allosteric regulation means binding at one site affects others: the first oxygen binding triggers conformational changes that propagate through subunit interfaces, breaking stabilizing salt bridges and enabling easier binding by remaining subunits. This 'all for one' behavior allows hemoglobin to load nearly completely in high-oxygen lungs and unload significantly in low-oxygen tissues, making it an extraordinarily efficient oxygen transporter.

Allosteric regulation is a mechanism by which enzymes are controlled through binding of effector molecules at sites separate from the active site; this can occur via negative feedback inhibition (where end products inhibit earlier enzymes to prevent overproduction) or positive feedback activation (where intermediates activate enzymes to accelerate production), with hemoglobin demonstrating both positive cooperativity (oxygen binding increases affinity for additional oxygen molecules) and negative cooperativity (binding of 2,3-BPG decreases oxygen affinity).

Hemoglobin demonstrates allosteric regulation through two conformational states (T-tense, low oxygen affinity; R-relaxed, high oxygen affinity). The heme group, a prosthetic organic molecule containing iron, binds oxygen at one site while coordinating with histidine residues. Oxygen binding induces conformational changes that propagate through the four subunits, creating positive cooperativity where each bound oxygen increases affinity for subsequent molecules. This allows hemoglobin to load oxygen efficiently in the lungs (high affinity at ~100 mmHg) and release it in tissues (lower affinity at ~40 mmHg). Two theoretical models explain this behavior: the MWC model (all subunits switch simultaneously between states) and the Sequential model (individual subunits change independently).

Allosteric enzymes catalyze committed steps by binding to sites other than the active site. Cooperative binding produces sigmoid velocity curves (like hemoglobin) when substrate binding to one subunit affects others. Allosteric enzymes have T-state (tense, low affinity) and R-state (relaxed, high affinity). Inhibitors stabilize T-state (decrease affinity), while activators stabilize R-state (increase affinity). This explains how allosteric regulation controls enzyme activity.

This section covers allosteric enzymes and protein structure. Allosteric enzymes exhibit cooperative binding described by the Hill equation (v = Vmax[S]^n/(K0.5^n + [S]^n)), where n > 1 indicates positive cooperativity (sigmoidal curve). Hemoglobin has n ≈ 2.8, showing positive cooperativity where the first oxygen binds most slowly and subsequent oxygens bind progressively faster. Enzyme regulation occurs through five mechanisms: allosteric regulation (R to T state transitions), covalent modification (phosphorylation), feedback inhibition, zymogen activation, and protein complex formation. The catalytic triad in serine proteases (serine, histidine, aspartate) enables peptide bond cleavage through proton transfer. Protein structure has four levels: primary (amino acid sequence), secondary (alpha helices, beta sheets stabilized by hydrogen bonds), tertiary (3D folding with hydrophobic interactions, disulfide bonds), and quaternary (multiple polypeptide chains). Alpha helices have 3.6 residues per turn, 1.5 Å rise per residue, and hydrogen bonds between residue i and i+4.

Two primary experimental methods determine three-dimensional protein structures. X-ray crystallography involves protein purification, crystallization, X-ray diffraction, data collection (360° rotation), electron density map generation, model fitting, and quality assessment using Ramachandran plots and Procheck. NMR spectroscopy determines structures in solution through isotopic labeling (15N, 13C, 2H), data collection, and analysis, providing average structures due to protein mobility in solution. Homology modeling predicts structures by exploiting sequence similarity between target and template proteins, involving template identification, multiple sequence alignment, model building using programs like MODELER, and quality assessment. Quaternary structure determination requires proteins with multiple subunits, with oligomeric status calculated by comparing native molecular weight (gel filtration chromatography) to denatured molecular weight (SDS-PAGE).

Protein structure prediction methods are divided into experimental and computational approaches. Experimental methods include X-ray crystallography (accurate but expensive at $100,000-$200,000, requires crystals, in vitro), NMR spectroscopy (accurate but less than X-ray, in vivo, limited to small proteins), and electron microscopy (low resolution). Computational methods predict structures for complex proteins where experimental methods fail, using template-based modeling (using known structures as templates) and template-free/ab initio methods (physics-based, no template required). Computational methods are particularly useful for medical and drug modeling applications.

X-ray crystallography determines molecular structures by directing X-rays at crystalline samples. The technique requires crystals because organic molecules are normally dynamic, rotating and changing orientation. Scientists form crystals by cooling and condensing compounds into ordered three-dimensional lattices where molecules occupy fixed positions. X-rays diffract when striking atomic planes within crystals, producing unique patterns dependent on molecular complexity. The experimental setup involves directing X-rays through crystals and capturing diffracted beams on detectors. Scientists conceptually divide crystals into unit cells with three dimensions (a, b, c), then systematically examine diffraction from different planes to gather structural information.

This section compares three major structural biology techniques. X-ray crystallography requires growing protein crystals, then exposing them to X-rays to produce diffraction patterns that are mathematically transformed to generate electron density maps. NMR spectroscopy measures atomic distances in solution, and computational algorithms construct models satisfying these constraints. Cryo-EM produces 2D projection images that are computationally reconstructed into 3D density maps, with atomic models fitted into these maps. The key difference is that cryo-EM data files are extremely large (250 MB+ for 3D maps) compared to X-ray structures, presenting unique computational challenges.

X-ray crystallography is the primary method for determining protein 3D structures, especially for proteins larger than 20 kilodaltons where NMR spectroscopy becomes impractical. The technique relies on X-rays with nanometer wavelengths interacting with crystalline protein lattices. When X-rays strike the crystal lattice, they diffract due to the matching scale between interatomic distances and X-ray wavelengths. The diffraction pattern captures information about atomic positions, which is transformed mathematically into an electron density map. Scientists then fit atoms and molecules into this density map to construct a detailed 3D structural model of the protein.